SC 13G/A
Amended Statement of Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001104659-22-016551
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
- 2026-08-14 SCHEDULE 13G/A · Point72 Asset Management, L.P. 7.6%
- 2026-07-24 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2026-05-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2026-05-13 SCHEDULE 13G · Adage Capital Management, L.P. 8.56%
- 2026-05-11 SCHEDULE 13D/A · Panacea Innovation Limited 16.1%
- 2026-05-08 SCHEDULE 13G · Point72 Asset Management, L.P. 6.2%
- 2026-05-07 SCHEDULE 13G/A · EcoR1 Capital, LLC 17.4%
- 2026-01-14 SCHEDULE 13D/A · Panacea Innovation Limited 19.99%
- 2025-11-14 SCHEDULE 13D/A · Redmile Group, LLC 9.9%
- 2025-11-14 SCHEDULE 13G/A · EcoR1 Capital, LLC 9.9%
- 2025-08-19 SCHEDULE 13D/A · Panacea Innovation Limited 20.0%
- 2025-05-23 SCHEDULE 13D · Redmile Group, LLC 9.9%
- 2025-05-21 SCHEDULE 13D · Panacea Innovation Limited 19.99%
- 2025-05-16 SCHEDULE 13D/A · Adiumentum Capital Fund I LP 19.99%
- 2025-05-15 SCHEDULE 13G/A · Redmile Group, LLC 9.9%
- 2025-02-06 SCHEDULE 13G · Panacea Venture Healthcare Fund II, L.P. 9.5%
- 2024-11-14 SC 13G/A · Citadel Advisors LLC 4.6%
- 2024-11-14 SC 13G/A · EcoR1 Capital, LLC 9.99%
- 2024-11-12 SC 13G/A · The Vanguard Group 3.18%
- 2024-11-04 SC 13G/A · The Vanguard Group 3.18%
Loading tv0330-atarabiotherapeuticsi.htm…